Indiana Sues OxyContin Maker Purdue Pharma Over Opioid Crisis

By Aaron Emerson

The state of Indiana is suing Purdue Pharma, alleging the pharmaceutical company played a role in its opioid problem.

Indiana filed the lawsuit Wednesday in Marion County, claiming the company contributed to the state’s opioid epidemic by misrepresenting the risks of addiction in its painkillers.

The company has “vigorously” denied the allegations, but Indiana is just the latest of many communities and states to sue Purdue for its role in opioid addiction.

Indiana is seeking penalties, damages, and an order halting the company’s conduct.

Indiana’s attorney general said Purdue Pharma accounted for almost 54 percent of branded opioid prescriptions paid by the state’s Medicaid programs since 2012, according to the Indy Star.

Purdue Pharma, based in Stamford, Connecticut, developed OxyContin in 1995. It was labeled as a medical breakthrough and has reportedly generated Purdue $35 billion in revenue.

The problem, though, is that Purdue misled the public, claiming OxyContin was less addictive than other opioids. They have already paid out hundreds of millions of dollars in settlements, which is nothing compared to the countless lives and families they have destroyed.